These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 6395289)
1. Monoclonal antibodies and bone marrow transplantation. Perticarari S; Presani G; Mangiarotti M; Andolina M Ric Clin Lab; 1984; 14(3):327-31. PubMed ID: 6395289 [No Abstract] [Full Text] [Related]
2. The use of monoclonal antibodies for purging autologous bone marrow in the lymphoid malignancies. Macintyre EA Clin Haematol; 1986 Feb; 15(1):249-67. PubMed ID: 3516492 [No Abstract] [Full Text] [Related]
3. Removal of acute lymphoblastic leukemia (ALL) cells from human bone marrow using monoclonal antibodies (MoAbs) and complement--a review. Hervé P; Racadot E Rev Fr Transfus Immunohematol; 1985 Nov; 28(5):447-54. PubMed ID: 3912922 [No Abstract] [Full Text] [Related]
5. Autologous bone-marrow transplantation in CALLA-positive acute lymphoblastic leukemia after in-vitro treatment with J5 monoclonal antibody and complement. Ritz J; Sallan SE; Bast RC; Lipton JM; Clavell LA; Feeney M; Hercend T; Nathan DG; Schlossman SF Lancet; 1982 Jul; 2(8289):60-3. PubMed ID: 6177990 [TBL] [Abstract][Full Text] [Related]
6. [A transient appearance of CALLA positive blastoid cells after allogeneic bone marrow transplantation in a patient with acute lymphoblastic leukemia]. Komatsu N; Takagi S; Amemiya Y; Sakamoto S; Miura Y Rinsho Ketsueki; 1987 Feb; 28(2):250-3. PubMed ID: 2952819 [No Abstract] [Full Text] [Related]
7. Clinical applications of monoclonal antibodies in acute leukemia. Ritz J; Bast RC; Takvorian T; Sallan SE Ann N Y Acad Sci; 1984; 428():308-17. PubMed ID: 6234835 [No Abstract] [Full Text] [Related]
8. Preclinical studies of a panel of 12 monoclonal antibodies in view of bone marrow purging in acute lymphoblastic leukemia. Racadot E; Herve P; Lamy B; Peters A Leuk Res; 1987; 11(11):987-94. PubMed ID: 2961950 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal-antibody-purged autologous bone marrow transplantation for relapsed non-T-cell acute lymphoblastic leukemia in childhood. Niemeyer CM; Ritz J; Donahue K; Sallan SE Haematol Blood Transfus; 1987; 31():67-74. PubMed ID: 2965082 [No Abstract] [Full Text] [Related]
10. Bone-marrow purging with monoclonal antibodies and human complement in ALL and AML. Majdic O; Sugita K; Touw I; Köller U; Stockinger H; Delwel R; Löwenberg B; Knapp W Haematol Blood Transfus; 1987; 31():86-8. PubMed ID: 3327791 [No Abstract] [Full Text] [Related]
11. An immunotoxin for immunologic manipulation of marrow ex vivo in autologous transplantation for common acute lymphoblastic leukemia. Herrmann R; Pelham J; Meyer B; Davis R; Raphael C; Kraft N; Atkins R Transplant Proc; 1986 Apr; 18(2):278-80. PubMed ID: 2938314 [No Abstract] [Full Text] [Related]
12. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement. Bast RC; Ritz J; Lipton JM; Feeney M; Sallan SE; Nathan DG; Schlossman SF Cancer Res; 1983 Mar; 43(3):1389-94. PubMed ID: 6337707 [TBL] [Abstract][Full Text] [Related]
13. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia. Guyotat D; Shi ZH; Campos L; Rabat M; Bonnier S; Poncelet P; Laurent JC; Fiere D Bone Marrow Transplant; 1990 Dec; 6(6):385-90. PubMed ID: 1982926 [TBL] [Abstract][Full Text] [Related]
14. In vitro treatment with monoclonal antibody prior to autologous bone marrow transplantation in acute lymphoblastic leukemia. Ritz J; Sallan SE; Bast RC; Lipton JM; Nathan DG; Schlossman SF Haematol Blood Transfus; 1983; 28():117-23. PubMed ID: 6345287 [No Abstract] [Full Text] [Related]
15. Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia. Sao H; Morishima Y; Ueda R; Yoshikawa S; Kodera Y; Ohno R; Takahashi T Jpn J Cancer Res; 1985 Dec; 76(12):1212-21. PubMed ID: 3937833 [TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies and immunotoxins in bone marrow transplantation: purging marrow of ALL or GVHD cells with preservation of stem cells. Kersey JH; Vallera D; Ramsay N; Filipovich A; Youle R; Neville D; Stong R; LeBien T Haematol Blood Transfus; 1985; 29():34-8. PubMed ID: 3896970 [No Abstract] [Full Text] [Related]
17. Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia. Morishima Y; Sao H; Ueda R; Morishita Y; Murase T; Kodera Y; Ohno R; Tahara T; Yoshikawa S; Kato Y Jpn J Cancer Res; 1985 Dec; 76(12):1222-9. PubMed ID: 3937834 [TBL] [Abstract][Full Text] [Related]
18. [Progress in the diagnosis and treatment of lymphoblastic leukemia]. Robak T Pol Tyg Lek; 1986 Feb; 41(7):220-4. PubMed ID: 2940521 [No Abstract] [Full Text] [Related]
19. 'Purging' of bone marrow and immunosuppression. Janossy G Br Med Bull; 1984 Jul; 40(3):247-53. PubMed ID: 6380636 [No Abstract] [Full Text] [Related]
20. Marrow grafting and immunotherapy in identical twins with hematologic malignancies. Fefer A; Buckner CD; Clift RA; Fass L; Glucksberg H; Mickelson EM; Neiman P; Storb R; Thomas ED Trans Assoc Am Physicians; 1973; 86():178-84. PubMed ID: 4596452 [No Abstract] [Full Text] [Related] [Next] [New Search]